Global Executive Summary Bulbospinal Muscular Atrophy Drugs Market: Size, Share, and Forecast CAGR Value Data Bridge Market Research analyses that the bulbospinal muscular atrophy drugs market which was USD 690.60 million in 2022, would reach up to USD 1,793.48 million by 2030, and is expected to undergo a CAGR of 12.67% during the forecast period. Bulbospinal Muscular Atrophy Drugs Market...